Abstract
Research and development (R&D) is very important to acquire new knowledge in various fields. The significance of public R&D is also increasing, especially related to health policy making, establishing basic databases, and enhancing basic and clinical science. The total budget of general public R&D in Korea was approximately ten billon US Dollars in 2008, but the proportion of health care research was just below 10%. In private sectors, it was three times the amount allocated to the public budget. In this article, recent trends in public R&D in Korea, especially related to health care policy and biotechnology are summarized. A brief overview of the application process for a specific policy fund is also described for early-stage researchers in these fields.
References
1. Survey of research and development in Korea, 2009. 2010. Seoul: Korea Institute of S&T Evaluation and Planning;9–10.
2. Homepage of Management Center For Health Promotion. accessed on May 10. 2011. Available at
http://mchp.hp.go.kr/.
3. Lee HS, Yong TS, Jeong SK. Understanding the Korean R&D investment among the OECD and its implication: KISTEP Issue Paper 2010-12. 2010. Seoul: Korea Institute of S&T Evaluation and Planning.
4. National Science & Technology Commission. Governmental report of investigation and analysis on the national research and development program in 2008. 2008. 09. Seoul: Ministry of Education, Science and Technology.
5. National Science & Technology Commission. Annual Report 2009. 2010. 05. Seoul: Ministry of Education, Science and Technology.
6. Ahn SK. Analysis on the national R&D investment activities of Major countries in 2009. 2009. Seoul: Korea Institute of S&T Evaluation and Planning.
7. KISTEP Statistic brief in 2009. 2010. Seoul: Korea Institute of S&T Evaluation and Planning.